Trials / Completed
CompletedNCT00530790
Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome
Clinical Evaluation of Ropinirole CR-RLS Tablets in Restless Legs Syndrome-Open-Label, Uncontrolled Study. Classification: Clinical Pharmacology, Exploratory
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to evaluate the safety, pharmacokinetic profile and efficacy in Restless Legs Syndrome patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ropinirole controlled release (CR)-RLS | White film-coated round-shaped tablet |
Timeline
- Start date
- 2007-08-23
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2007-09-17
- Last updated
- 2018-09-26
- Results posted
- 2009-07-24
Locations
11 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00530790. Inclusion in this directory is not an endorsement.